Isotopically Labeled Compounds
Cambridge Isotope Laboratories N-METHYL-2-PYRROLIDINONE-D9 (D, 99%), 1 G, 185964-60-7
N-METHYL-2-PYRROLIDINONE-D9 (D, 99%), 1 G, 185964-60-7
Cambridge Isotope Laboratories Acetonitrile-D3 (D, 99.8%), 10 X 0.5Ml, 2206-26-0
Acetonitrile-D3 (D, 99.8%), 10 X 0.5Ml, 2206-26-0
Cambridge Isotope Laboratories DIETHYL ETHER-D10 (D, 99%), 1 G AMP, 2679-89-2
DIETHYL ETHER-D10 (D, 99%), 1 G AMP, 2679-89-2
Cambridge Isotope Laboratories SODIUM DEUTEROXIDE (D, 99.5%) 40% IN D2O, 100 G, 14014-06-3
SODIUM DEUTEROXIDE (D, 99.5%) 40% IN D2O, 100 G, 14014-06-3
Cambridge Isotope Laboratories L-ALANINE (2-13C, 99%), 0.25 G, 62656-85-3
L-ALANINE (2-13C, 99%), 0.25 G, 62656-85-3
Cambridge Isotope Laboratories L-ALANINE (1-13C, 99%), 0.5 G, 21764-56-7
L-ALANINE (1-13C, 99%), 0.5 G, 21764-56-7
Medchemexpress LLC DC-LC3in-D5 | 2868312-73-4 | 98.6% | C19H22Cl2N2O3 | 25 MG
DC-LC3in-D5 is an autophagy inhibitor that functions by attenuating LC3B lipidation. It directly binds with LC3B and disrupts the interaction between LC3B and LBP2 with an IC50 of 200 nM. This compound has potential applications in anti-HCV (Hepatitis C Virus) research and combination therapies for cancer, owing to its autophagy-inhibiting properties.
- Attenuates LC3B lipidation
- Binds with LC3B and disrupts LC3B-LBP2 interaction
- Exhibits an IC50 of 200 nM for disrupting LC3B-LBP2 interaction
- May contribute to anti-HCV or combination research in cancer
- Available at 98.62% purity
- Demonstrates high selectivity to LC3A/B in the proteome
- Exhibits potent covalent reactivity and selectivity to LC3A/B in HeLa cells
- Disruption of LC3B lipidation, inhibition of autophagic vesicle formation, and accumulation of p62 in HeLa cells
Cayman Chemical MIltefosIn-d4 1mg
An internal standard for the quantification of miltefosine by GC- or LC-MS
Cayman Chemical CapsaIcIn-d3 1mg
An internal standard for the quantification of capsaicin by GC- or LC-MS
Medchemexpress LLC Raloxifene-d4 hydrochloride | 1188263-47-9 | 98.6% | 514.07 | 500 UG
Raloxifene-d4 hydrochloride is the deuterium labeled form of Raloxifene, a benzothiophene-derived selective estrogen receptor modulator (SERM). It exhibits estrogen-agonistic effects on bone and lipids, and estrogen-antagonistic effects on the breast and uterus. This compound is utilized in breast cancer and osteoporosis research.
- Can be used as a tracer
- Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Exhibits estrogen-agonistic effects on bone and lipids
- Shows estrogen-antagonistic effects on the breast and uterus
- Valuable for breast cancer and osteoporosis research
Medchemexpress LLC Nonanoic acid-d4 | 1219795-27-3 | 1 MG
Nonanoic acid-d4, also known as Pelargonic acid-d4, is a deuterium-labeled version of Nonanoic acid. Nonanoic acid is a naturally occurring saturated fatty acid composed of nine carbon atoms. This compound is known to significantly decrease bacterial translocation, boost antibacterial activity, and notably increase the production of porcine β-defensins 1 (pBD-1) and pBD-2.
- Stable isotope-labeled compound.
- Can be utilized as a tracer in various research applications.
- Serves as an internal standard for quantitative analysis using techniques such as NMR, GC-MS, or LC-MS.
- Valuable for pharmacokinetic and metabolic studies due to the potential of deuteration to influence drug profiles.
- Significantly reduces bacterial translocation.
- Enhances antibacterial activity.
- Remarkably increases the secretion of porcine β-defensins 1 (pBD-1) and pBD-2.
Medchemexpress LLC Isoformononetin-d3 | 1 MG
Isoformononetin-d3 is a deuterium-labeled derivative of Isoformononetin, an isoflavone that functions as an analog of Daidzein. Isoformononetin has been noted for its immunoprotective effects. This compound has a molecular formula of C16H9D3O4 and a molecular weight of 271.28.
- Deuterium-labeled compound
- Analog of Daidzein
- Exhibits immunoprotective effects
- Molecular formula: C16H9D3O4
- Molecular weight: 271.28
